Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021

SELL
$80.49 - $108.67 $389,732 - $526,180
-4,842 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $115,377 - $135,414
-1,343 Reduced 21.71%
4,842 $424,000
Q2 2020

Jul 14, 2020

SELL
$73.37 - $98.18 $56,641 - $75,794
-772 Reduced 11.1%
6,185 $607,000
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $24,961 - $37,844
-387 Reduced 5.27%
6,957 $530,000
Q4 2019

Jan 22, 2020

BUY
$72.13 - $90.25 $529,722 - $662,796
7,344 New
7,344 $650,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisor Shares Investments LLC Portfolio

Follow Advisor Shares Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.